OUR 2026 PARTNERS
-
PLATINUM PARTNERS
Fish & Richardson
Website: www.fr.com/industries/life-sciences
Fish & Richardson has represented pioneering life science innovators from our earliest days. We work closely with life sciences companies to help them achieve their strategic IP goals through acquisition, partnering, licensing, financing, and enforcement. We do this by bringing a unique holistic approach to our clients’ IP matters, fostered by the collaboration between our patent prosecution, litigation, and regulatory practices. We have helped our clients build valuable patent portfolios worth billions of dollars, score big victories at the Patent Trial and Appeal Board (PTAB), and win bet-the-company cases in court. When life sciences clients come to Fish to build an IP strategy, they know that we will leave no stone unturned when crafting creative and comprehensive solutions to maximize the value of their IP.
Maiwald Intellectual Property
Website: www.maiwald.eu/en
As one of Germany’s largest and best-known firms in the field of intellectual property (IP), providing optimal services to our clients is of paramount importance to us. Our team comprising about 250 people in Munich and Düsseldorf works closely with each other and with foreign associates, always with an eye to the client’s particular needs, regardless of the particular industry or type of company, whether start-up, medium-sized firm or large corporation, in Germany and worldwide. We at Maiwald will do everything to ensure that all your IP matters are handled with competence and commitment.
You can rely on Maiwald’s wide-ranging expertise. We provide a full range of services covering all aspects of IP law. Our highly qualified patent attorneys and attorneys-at-law unite all of the most important skills one would expect of an interdisciplinary team: sound legal knowledge, business proficiency and a broad range of technical and scientific know-how. And, it goes without saying, absolute professionalism, efficiency and close attention to the needs of each individual client. So you may be assured of receiving the best possible advice on all IP-related issues based on our proven competence and industry knowledge.
Mewburn Ellis
Website: www.mewburn.com
Mewburn Ellis is one of leading P firms in Europe, showcasing an exceptional breadth and depth of expertise to address all your IP needs, both now and in the future. With five European offices – London, Bristol, Manchester, Cambridge, and Munich – we operate seamlessly as one unified firm. This ensures our clients benefit from a diverse range of relevant skills and knowledge, delivered by some of the brightest minds in the IP profession. Our IP specialists will guide you through every stage of the IP lifecycle. We offer comprehensive advice on patent, trade mark, and registered design protection, as well as assistance with any IP-related disputes and legal or commercial requirements. If you need help reviewing your IP assets, we can conduct IP Audits to evaluate your existing IP portfolio, identifying related risks and opportunities, and providing strategic advice and guidance aligned to your business objectives.
At Mewburn Ellis, we bring passion and commitment to our clients, immersing ourselves in their businesses to understand not just their immediate needs, but also their long-term goals. This strategic and personalised approach allows us to deliver creative and cost-effective solutions tailored to each client's specific requirements.
GOLD PARTNERS
AWA
Website: www.awa.com/en
AWA is a leading intellectual property firm with over 400 employees across 20+ offices in Belgium, China, Denmark, Hong Kong, Norway, Sweden and Switzerland. Our clients are innovative companies, ranging from local start-ups to global giants.
We supply a full-service offering in prosecution, dispute litigation, aftermarket services, legal advice, strategy and commercialisation. Our IP professionals are experts in patents, trademarks, design, copyright and domain names – all as passionate about your innovations and brands as you are.
AWA was founded in 1897 by the Swedish engineer Anders Wilhelm Anderson. His initials form our company name and remind us of our proud history and the experience we bring to all our clients.
Carpmaels & Ransford
Website: www.carpmaels.com
Carpmaels & Ransford LLP is a leader in the European IP market, having driven innovation in the industry for over 200 years. The firm advises clients on all aspects of intellectual property, including drafting, filing and prosecuting patent and trademark applications; drafting and negotiating licence agreements and other commercial IP agreements; advising on the transfer of property rights; assisting clients with patent restoration matters; and conducting enforcement and revocation litigation.
The firm has one of Europe’s largest IP teams serving blue-chip clients across the globe, including Johnson & Johnson, Bristol Myers Squibb, Novartis, Ionis Pharmaceuticals, Mars, Gilead, Raytheon, Regeneron, Takeda, Allergan and Xeros. The firm’s attorneys have considerable technical knowledge, bringing together experience from industry-leading companies, academic research at leading universities and extensive patent expertise in the areas of pharmaceuticals, biotechnology, engineering, tech, chemistry, materials, supplementary protection certificates and information and communication technologies and standards.
Through its fully integrated dispute resolution and transactions teams, the firm is able to provide a holistic service to clients which supports their IP needs from inception to commercialisation. The dispute resolution team, made up of experienced solicitors, barristers and patent attorney litigators, represents clients at all levels of the European Patent Office. The team is also adept at conducting enforcement litigation and revocation actions before the UK Intellectual Property Office and patent, copyright, trademark and other IP litigation in the English courts and the Court of Justice of the European Union, often advising in cases where parallel or related litigation is ongoing in courts across Europe or in the United States.
As a European IP firm with litigators and patent attorneys under one roof, Carpmaels & Ransford is looking forward to offering clients the chance to both obtain UPs using the existing EPO procedure and enforce their patents across Europe in the UPC.
Choate, Hall & Stewart LLP
Website: www.choate.com
Choate provides leading life sciences companies and institutions with integrated legal services that enable our clients to achieve success. Our team of life sciences attorneys, many with advanced degrees, use their scientific and strategic expertise to advise clients on IP protection and strategies, financings, mergers and acquisitions, and strategic transactions. Choate stands out in a legal marketplace which is crowded, intensely competitive and populated by firms which increasingly look, act and think alike. Our unique model leads to a special client experience.
De Vries & Metman
Website: dvme.nl/en
De Vries & Metman is a prominent Dutch patent firm with offices in Amsterdam, Arnhem, Breda, and Eindhoven, known for its personal approach to patent work. The firm guides clients through all aspects of patent procedures, with clear, business-focused advice, covering sectors including chemistry, life sciences, ICT, electronics, and mechanical and medical technology. De Vries & Metman combines deep specialist expertise with a strong commitment to helping its clients turn their innovations into commercial value.
DF-MP
Website: df-mp.com
df-mp is a leading European IP law firm based in Munich. Founded in 2000, the firm delivers expert advice on patent prosecution, portfolio management, trademark law, and SPCs to clients ranging from SMEs to global corporations.
df-mp is particularly renowned for its high-stakes litigation practice across the life sciences (df-mp life), technology, and telecommunications sectors (df-mp tech). Operating internationally and before the UPC, EPO, and German courts, the firm frequently coordinates complex cross-border infringement and nullity proceedings.
df-mp’s attorneys have been involved in various high-profile patent litigation proceedings, many of which have had international implications and required df-mp to carry out a coordinating role. For example, df-mp’s biotech/pharmaceutical patents group (also known as “df-mp life”, led by Ulrich Dörries, Sandra Pohlman and Elisabeth Greiner) has handled a number of newsworthy litigation matters, including large and complex EPO oppositions and patent nullity actions before the German Federal Patent Court and the Federal Supreme Court in the area of product, formulation and use patents concerning blockbuster small molecule drugs and biologics.
df-mp and its attorneys are consistently recognised among Germany’s leading patent firms by IAM Patent 1000 (2011–2026), IP Stars (2014–2026), JUVE (2022–2025), and WTR 1000 for excellence in patent litigation, prosecution, nullity proceedings, and trademark practice.
Gemini Law
Website: www.geminilaw.com
Gemini attorneys are among the most experienced and successful at helping manufacturers of biopharma products navigate IP barriers to access the U.S. market. Gemini has particular expertise in patent strategy and litigation relating to biosimilar, biobetter, generic and 505(b)(2) products, as well as collateral issues concerning the Hatch Waxman and BPCIA regulatory schemes. Gemini is also very experienced in counseling early-stage biotech companies to optimize patent portfolios and mitigate the risk posed by competitors’ IP, as well as IP issues related to licensing and development transactions. Gemini offers “end to end” counseling on IP issues in support of biopharma product development and launch in the U.S., including:
- Litigation risk mitigation and avoidance
- Patent & trade secret design-around strategies
- Patent portfolio optimization
- Biosimilar (BPCIA) litigation & regulatory strategy
- Hatch Waxman litigation & regulatory strategy
- "Biobetter" & "fast follow-on" product litigation & regulatory strategy
- Pharmaceutical device-related litigation & regulatory strategy
- IP & regulatory issues concerning healthcare AI
- CREATES Act requests & litigation
- Section 1782 discovery requests for use in foreign litigation
- Global coordination of litigation strategy concerning biosimilar, generic and biobetter products
- Patent landscaping and freedom-to-operate opinions
- IP-related licensing, development & manufacturing transactions
- Lobbying and legislative initiatives relating to the BPCIA and Hatch Waxman laws
Groombridge Wu
Website: www.groombridgewu.com
Groombridge, Wu, Baughman & Stone LLP is a patent litigation firm. We try cases in court, in arbitrations, in the International Trade Commission, and before the Patent Trial and Appeal Board, and we argue appeals before the Federal Circuit. We are nationally recognized thought leaders on patent issues, as well as on issues of social justice. And we are teachers, training the next generation of patent litigators. We have a long track record of achieving successful outcomes for our clients both in the courtroom and in the boardroom.
Hoffmann Eitle PartmbB
Website: www.hoffmanneitle.com/en
HOFFMANN EITLE is a leading European intellectual property firm with more than 160 IP professionals across eight offices in Munich, London, Düsseldorf, Hamburg, Milan, Madrid, Amsterdam, and Barcelona. Headquartered in Munich and supported by 50 partners, the firm delivers strategic, pan-European IP services through a fully integrated network.
Founded in 1892, HOFFMANN EITLE has grown into one of Europe’s largest and most respected IP firms, combining a long tradition of excellence with a modern, forward-looking approach. The firm is consistently ranked among the leading IP firms in Europe and holds the number one position among the Top 50 firms for European Patent Office (EPO) patent applications in 2025. It is also widely recognised as a market leader in EPO opposition proceedings, with an unrivalled scale and depth of expertise.
A particular strength lies in life sciences and pharmaceuticals, where highly specialised interdisciplinary teams combine deep scientific expertise with decades of experience in European patent grant, opposition and nullity proceedings, as well as Supplementary Protection Certificates (SPCs) and broader pharmaceutical lifecycle protection strategies. HOFFMANN EITLE has developed significant experience in proceedings before the Unified Patent Court (UPC), representing clients in high-profile infringement and revocation actions and advising on litigation strategy, portfolio management and the effective use of the European patent enforcement framework.
Hylton-Rodic Law
Website: www.hyltonrodiclaw.com
Hylton-Rodic Law is an intellectual property law firm working collaboratively with our clients to provide personalized legal representation of the highest quality that is responsive, cost-effective, and efficient. All of our attorneys have strong scientific backgrounds and the ability to focus on legal issues while knowing how to navigate complicated technical problems. Our clients run the gamut from start-ups to large multinational companies. Hylton-Rodic Law provides a wide range of intellectual property services, including patent procurement, patent portfolio development and management, patent-related risk assessment, trade secrets, trademarks, and IP licensing across industries - Biotechnology, Pharmaceuticals, Consumer Goods, and Chemicals.
King & Wood
Website: www.kingandwood.com/global/en/home.html
Please visit our website for more information.IPD Analytics
Website: www.ipdanalytics.com
IPD Analytics is the pharmaceutical insights platform built for the demands of pharma litigation and patent law. For over two decades, IPD's expert analyst team has tracked each dimension of the drug lifecycle, from patent filing and regulatory approval through generic entry, biosimilar competition, and market loss of exclusivity, covering 4,000+ on-market and in-development drugs across the US and Europe.
IPD analysts are in the courtroom, attending district court proceedings, IPR and post-grant hearings, EPO oppositions, CJEU and UPC matters, and Federal Circuit appeals, capturing real-time insights on legal arguments, judge reactions, and expert witness performance. That on-the-ground coverage feeds directly into the platform and published reports, so law firms receive intelligence on active matters as it happens.
Beyond coverage, IPD provides district court, IPR, PGR, settlement, and timing analytics that help firms benchmark PIV outcomes, settlement rates, and litigation timelines at the patent-drug level by jurisdiction, judge, counsel, and manufacturer. For law firms, that means a single platform that sharpens business development, supports active matters, and helps attorneys walk into any case knowing exactly how similar ones have played out.
Licks
Website: www.lickslegal.com
Licks Attorneys is Brazil's largest patent litigation practice and one of Latin America's leadin intellectual property, regulatory and technology law firms.
With more than 350 professionals across five offices in Brazil and an international presence in Tokyo, the firm combines legal, scientific and technical expertise to assist innovative companies in some of the most complex disputes and strategic matters in the country.
Licks Attorneys has litigated more than 3,000 cases since 2011, including 630+ patent litigation matters at trial and appellate levels, and is widely recognized as the market leader in high-stakes intellectual property disputes involving pharmaceuticals, biotechnology, telecommunications, software, electronics, medical devices, agribusiness and other technology-driven industries.
The firm's multidisciplinary team includes over 90 attorneys, 15 patent practice heads and advisors, and more than 70 technical specialists, including engineers, pharmacists, biologists, chemists and data scientists. This unique combination of legal and scientific expertise allows the firm to develop sophisticated strategies for technically complex matters involving patents, life sciences, regulatory affairs, standard-essential patents (SEPs), telecommunications, trademarks, unfair competition and commercial litigation.
Licks Attorneys is particularly recognized for its success in patent enforcement and defense, achieving a 97% success rate in SEP preliminary injunction adjudications, a 95.1% success rate in preliminary injunction patent cases, and a 91.1% success rate in patent disputes decided on the merits involving global licensing agreements.
Beyond litigation, the firm is also home to Brazil's largest patent acquisition practice, with one of the country's largest teams of patent specialists and a 92% patent allowance rate for applications prosecuted on behalf of clients.
The firm's excellence is consistently by leading international legal directories, including Chambers & Partners, The Legal 500, IAM Patent 1000, WTR 1000, Lexology Index, IP Stars and Leaders League, which have described Licks Attorneys as "a litigation juggernaut," "the best patent law firm for SEP litigation in Brazil," and "the best firm for patent owners looking to enforce their rights against infringers in Brazil."
Through technical excellence, business-oriented solutions and international collaboration, Licks Attorneys helps multinational and domestic companies protect, enforce and maximize the value of their intellectual assets while navigating Brazil's complex legal and regulatory landscape.
Potter Clarkson
Website: www.potterclarkson.com
Leading European intellectual property law firm, Potter Clarkson helps companies, organisations, and individuals across all sectors of business to understand, create, protect, and defend the commercial value of their innovations anywhere in the world. Its 200-strong specialist team of patent attorneys, trade mark attorneys, litigators, and licensing specialists, operate from dedicated offices in the UK, Sweden, and Denmark.
Potter Clarkson is widely recognised as one of Europe’s leading intellectual property law firms, particularly renowned for its expertise in life sciences disputes. The firm’s contentious practice regularly handles high-profile litigation across major jurisdictions worldwide, including proceedings before the European Patent Office (EPO) and, more recently, the Unified Patent Court (UPC). With multiple actions currently underway, Potter Clarkson is actively leveraging the EPO’s existing procedures to obtain Unitary Patents and enforce patent rights across Europe through the UPC.Potter Clarkson is widely recognised as one of Europe’s leading intellectual property law firms, particularly renowned for its expertise in life sciences disputes. The firm’s contentious practice regularly handles high-profile litigation across major jurisdictions worldwide, including proceedings before the European Patent Office (EPO) and, more recently, the Unified Patent Court (UPC). With multiple actions currently underway, Potter Clarkson is actively leveraging the EPO’s existing procedures to obtain Unitary Patents and enforce patent rights across Europe through the UPC.
Potter Clarkson is widely recognised as one of Europe’s leading intellectual property law firms, particularly renowned for its expertise in life sciences disputes. The firm’s contentious practice regularly handles high-profile litigation across major jurisdictions worldwide, including proceedings before the European Patent Office (EPO) and, more recently, the Unified Patent Court (UPC). With multiple actions currently underway, Potter Clarkson is actively leveraging the EPO’s existing procedures to obtain Unitary Patents and enforce patent rights across Europe through the UPC.
Reddie & Grose
Website: www.reddie.co.uk
Reddie & Grose is a European Intellectual Property firm and our team of over 100 IP professionals are working from our offices in London, Cambridge, Munich and The Hague. We handle the full range of IP rights including patents, trade marks, registered designs and plant varieties. Within these areas the team are experts in drafting, filing, prosecution, opposition, enforcement, defence and dispute resolution, and advise on IP strategy at all stages in the development of our clients’ portfolios. We help clients to overcome obstacles by whatever method best fits the strategy for that client. We partner with them and give them recommendations for how they should best protect their IP.
Simmons & Simmons
Website: www.simmons-simmons.com/en/expertise/service/intellectual-property/patents
Our international Patent team seamlessly integrates the specialized expertise of a boutique practice with the extensive service offerings of a major international firm. Recognized in the market for our high-calibre clients and active involvement in leading global patent cases, we stand as a trusted force in the European legal landscape; with offices and well established patent experts in London, Amsterdam, Paris, Munich and Milan and with Pharma & Biotech as one of our firm’s four core sectors.
Leveraging our extensive experience, we adeptly guide clients through specialised procedures, including infringement seizures, preliminary injunctions, patent infringement actions, patent nullification actions, and non-infringement declarations. With over 45 years at the forefront of IP law and practice, our international reputation is anchored in a pre-eminent track record in complex patent litigation (alongside a market-leading IP transactions and regulatory practices). Our comprehensive suite of services offers a "one-stop-shop" for pharma and biotech clients needing advice and strategic partnership on patents and other areas of IP.
Simmons and Simmons has played a pivotal role in the development of the Unified Patent Court (UPC) system. Our partner, Kevin Mooney, is acknowledged as one of the "fathers of the UPC", if not “Mr UPC”. Positioned at the forefront of every aspect of the new system, we don't just advise on the law – we actively shape it.
Sterne Kessler
Website: www.sternekessler.com
Sterne, Kessler, Goldstein & Fox is a full-service intellectual property law firm that provides innovative solutions tailored to your business and industry. Since our founding in 1978, we have grown to become one of the largest IP specialty law firms in the United States. We collaborate across the full spectrum of IP to deliver real results for our clients—from patent and trademark prosecution, to patent litigation in federal district and appellate courts, strategic IP counseling, due diligence, and post-grant proceedings before the Patent Trial and Appeal Board.
Our team includes attorneys, patent agents, and technical specialists with 100+ advanced degrees, including 60+ Ph.D.s,, in science and engineering disciplines. We work with the world’s leading innovators and brands, ranging from individual inventors and startups to renowned universities and Fortune 500 companies.
We are proud to be one of the most highly regarded IP specialty law firms, and we have cultivated an environment that is welcoming, inclusive, and intellectually stimulating. And we’re honored that our attorneys and staff have voted Sterne Kessler as a Washington Post “Top Workplace” for 10 years running.
Van Bael & Bellis
Website: www.vbb.com
Van Bael & Bellis is a leading independent international law firm, headquartered in Brussels with offices in London and Geneva. Our cross-disciplinary life sciences team is top-ranked in the leading directories.
We advise some of the world’s largest pharmaceutical, biotechnology and medical device companies on the full range of EU and Belgian matters arising across product life cycles, including collaborations and licensing, distribution issues, registration, early market access schemes, pricing and reimbursement strategies, pre- and post-marketing regulations, product liability, clinical trials, data exclusivity, orphan medicines, advertising and promotion, pharmacovigilance, hospital supplies under public procurement rules, parallel imports, patient support schemes, digital healthcare issues, advanced therapies, patent litigation and dispute resolution.
The firm is a co-founder of the Life Sciences Practice Group, an informal network of independent specialist life sciences law firms across 27 jurisdictions. Our lawyers speak at life sciences events around the globe.
Venable LLP
Website: www.venable.com
Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, high-net-worth entrepreneurs, and other individuals. With more than 850 professionals across the country, including in California, Colorado, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' objectives in the United States and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit https://www.venable.com/
SOLUTION PARTNERS
Flank AI
Website: flank.ai
Enterprise legal teams spend most of their capacity on routine, rules-based work - NDAs, DPAs, vendor agreements, intake triage. Inexpensive work, done by expensive resources. Flank closes that gap.
Flank deploys supervised AI agents that get the work done, rather than making lawyers faster at doing it themselves. Each agent plugs into the tools your team already runs on and works from your own templates, playbooks, and fallback positions. It picks up requests around the clock and drafts, reviews, redlines, negotiates, and answers end-to-end, then routes finished work to your legal team for sign-off. Business users send an email and get completed work back: no portal, no login, no change management.
Our forward-deployed engineers map your workflows, wire in your systems, and configure your agents to your team's rules. Most go live in two to four weeks, and Flank stays on to maintain and expand the deployment. Legal keeps full control throughout: set the guardrails, supervise and own every output.
Customers include: Accor, Financial Times, Simmons & Simmons and Axel Springer.
Patlytics
Website: www.patlytics.ai
Patlytics is an AI-powered patent intelligence platform built for the entire IP lifecycle. From drafting and office actions to invalidity, FTO, and SEP analysis, Patlytics is the only end-to-end solution covering both prosecution and litigation in a single platform — replacing the fragmented point tools that have long defined the industry.
Founded in 2023, Patlytics is trusted by Am Law 100 law firms and global enterprises including Ford and Samsung, and is rapidly becoming the standard for how leading IP teams work. Built by technologists and IP professionals alike, Patlytics combines the rigor of purpose-built AI with deep domain expertise to give practitioners faster, more precise results on their most complex matters.
RWS
Website: www.rws.com/intellectual-property-services
RWS is a content solutions company, powered by technology and human expertise. We grow the value of ideas, data and content by making sure organizations are understood. Everywhere.
Our proprietary technology, 45+ AI patents and human experts help organizations bring ideas to market faster, build deeper relationships across borders and cultures, and enter new markets with confidence – growing their business and connecting them to a world of opportunities.
It’s why over 80 of the world’s top 100 brands trust RWS to drive innovation, inform decisions and shape brand experiences.
With 60+ global locations, across five continents, our teams work with businesses across almost all industries. Innovating since 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).
More information: rws.com
Solve Intelligence
Website: www.solveintelligence.com
Please visit our website for more information.MEDIA PARTNERS
Global Legal Group
Website: www.glgroup.co.uk
Global Legal Group is an independent digital media company based in central London. Our clients are private practice and in-house lawyers, multinational corporations, and professional services firms in over 190 countries around the world.Founded in 2002, Global Legal Group’s first product was the International Comparative Legal Guides (ICLG) series, which has grown into a world-renowned legal resource that covers the law in more than 192 jurisdictions and across 58 practice areas.Since 2009, GLG has also produced Commercial Dispute Resolution, an online news and print magazine for litigation and arbitration specialists. In 2011, GLG introduced Global Legal Insights, an essential analytical resource detailing current legal issues spanning 16 practice areas, and, in 2014, African Law & Business was unveiled. Since 2012, GLG has also hosted a successful series of conferences and events, including the annual Global Class Actions Symposium, the premier event for international class actions specialists.Our mission is to provide outstanding performance for our clients and partners. We provide the digital technologies and expertise that they need to boost their brand exposure and market reach, as well as access to the world’s leading online network of legal experts. By only partnering with the leading legal and business authorities, we also ensure that the information we provide is topical, enlightening and authoritative, making our products the go-to resource.
JUVE
Website: www.juve-patent.com
JUVE Patent is an English-language online platform offering daily, independent reporting on the European patent market. Launched in 2018, it builds on JUVE’s long-standing expertise in legal and industry journalism, expanding this perspective to litigation, the UPC, the European Patent Office, and developments within law firms and corporate IP departments. JUVE Patent provides news, analysis, rankings, and market insights with a strong focus on France, Germany, the Netherlands, and the UK.
Our editorial team delivers well‑researched litigation coverage, transparent rankings, and comprehensive background reporting. Founded in 1997 and based in Cologne, JUVE is known for high‑quality, independent journalism across the legal and tax sectors—supporting professionals with reliable insights for strategic decision‑making in a dynamic European IP landscape.
Why Partner with Life Science Legal Strategy Summit Europe?
Access Europe's Senior Life Science Legal Decision-Makers
Partnering with LSLS puts your brand in front of the people who matter most. With over 50% of the audience made up of senior in-house counsel from pharma and biotech companies, including Chief Legal Officers, General Counsel, and Heads of IP, Regulatory and Competition Law, LSLS offers unrivalled access to the practitioners actively shaping life science legal strategy across Europe.
Build High-Quality Relationships That Last
With 15+ hours of dedicated networking built into the two-day programme, LSLS connects you with 450+ senior legal professionals, more than 50% of whom are in-house counsel. It is the ideal environment to forge meaningful connections and turn conversations into lasting commercial relationships.
Showcase Your Solutions Across the Full Legal Strategy Spectrum
LSLS is designed to move beyond theory into practical application. Partners can demonstrate how their solutions address real legal challenges, from UPC litigation and SPC strategy to EU Pharma Package compliance, competition scrutiny, and M&A transactions, directly to senior decision-makers seeking proven tools they can implement immediately.
Position Your Brand as a Life Science Legal Thought Leader
LSLS is where the life science legal community comes to learn, benchmark, and lead. Through keynote panels, expert roundtables, and innovation showcases, partners can share insights alongside private practitioners, regulators, patent offices, judges, and competition authorities. Partnering allows you to build credibility, demonstrate expertise, and be part of the conversations driving the future of life science legal strategy.
Interested in how you can get involved with Life Science Legal Strategy Summit 2026?
Based on your objectives, we can create bespoke packages for you. From presenting your expertise on stage to partnering with us to deliver networking activities. Partner with us in 2026 to showcase your brand and make valuable new connections. Opportunities include thought leadership, branding, and networking.
Discuss your objectives with Duncan Henderson, Commercial Partnerships Director, [email protected]
Hear From Our Previous Sponsors
Loading videos...